Researchers share results of MVA-BN-respiratory syncytial virus vaccine human challenge trial

Glass laboratory flasks on light table

Researchers reported the immunogenicity, efficacy, and safety of the MVA-BN (modified vaccinia Ankara-Bavarian Nordic)-RSV (respiratory syncytial virus) vaccine against RSV-A (RSV subtype A) Memphis 37b strain in a human challenge trial.

7 Simple Ways To Boost Online Web Traffic For Your Business This Festive Season

Previous article

‘Alice, Darling’ trailer: It’s tears and fears with this new psychological thriller

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News